NCI Recovery Act Web Site Highlights Small Businesses Driving Innovation in Cancer Care || NCI Cancer Bulletin for April 19, 2011 - National Cancer Institute

NCI Recovery Act Web Site Highlights Small Businesses Driving Innovation in Cancer Care

With the help of ARRA funds, BioFortis upgraded its technology platform (Labmatrix), which helps researchers evaluate large amounts of data more efficiently

The NCI Recovery Act Web site features a new article about two small businesses that have been able to advance new technologies to improve cancer care with the support of funding made available by the American Recovery and Reinvestment Act (ARRA), also known as the Recovery Act.

The two companies, Columbus Nanoworks and BioFortis, have also received funding from NCI’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which fund small businesses to stimulate technological innovation and collaboration.

The combined assistance is allowing the small businesses to advance potentially life-saving technologies and products. Columbus Nanoworks is developing magnetic nanoparticle reagents for the detection of cancer cells, and BioFortis upgraded its technology platform (Labmatrix), which helps researchers evaluate large amounts of data more efficiently

NCI Cancer Bulletin for April 19, 2011 - National Cancer Institute